Tag: Lausanne
Switzerland: Stage III hypertension in patients after mRNA-based SARS-CoV-2 coronavirus vaccination with Pfizer/Biontech & Moderna
On January 11th 2021, the vaccination Center in Lausanne, a city of 140’000 inhabitants in western Switzerland, started the COVID-19 vaccination with mRNA-based vaccines. More...